KPV 10 mg / 30 mg

Description

Research Overview

KPV is a short tripeptide composed of lysine, proline, and valine and corresponds to a fragment associated with alpha-melanocyte-stimulating hormone research. Laboratory studies have investigated KPV in experimental models involving peptide signaling, inflammatory-response pathways, and cellular interactions. These areas remain research contexts rather than treatment claims. Atlas Performance provides KPV with concise sequence identification, labeled strength options, and transparent documentation status.

Specifications

Sequence: Lys-Pro-Val | Available strengths: 10 mg and 30 mg | Format: research vial | Category: research peptide

Certificate of Analysis

Documentation pending — COA will be published as available.

For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.

Clear product information • Testing documentation as available • 3–4 hour response target